IDV vehicle

36F79721D0094

65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
OfficeNAC FEDERAL SUPPLY SCHEDULE (36F797)
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIXED PRICE WITH ECONOMIC PRICE ADJUSTMENT
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$380.7M
Start dateFeb 15, 2021
Current end dateNot available
Potential end dateNot available
Latest award activityJul 31, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 93 of 93 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 31, 2026P00094$0ADDITION
Jul 31, 2026P00096$0NDC CHANGE
Jul 29, 2026P00095$0PPR
Jul 13, 2026P00093$0SHORT TERM EXT
Jul 10, 2026P00092$0PPR
May 14, 2026P00091$0EVERGREEN MODIFICATION
May 12, 2026P00090$0DELETIONS
May 7, 2026P00089$0ADMIN
Mar 11, 2026P00087$0DELETIONS
Feb 27, 2026P00086$0NDC CHANGE
Feb 17, 2026P00085$0PRODUCT DELETION
Jan 29, 2026P00083$0SHORT TERM EXTENSION
Jan 29, 2026P00084$0PPR
Dec 10, 2025P00082$0LIFE CYCLE CHANGE
Dec 8, 2025P00081$0NDC CHANGE
Dec 2, 2025P00080$02026 PUBLIC LAW
Nov 15, 2025P00079$0PPR
Oct 7, 2025P00077$0TC CHANGE
Aug 11, 2025P00075$0ADDITION
Jul 21, 2025P00074$0LIFE CYCLE CHANGE
Jun 26, 2025P00073$0PRODUCT DELETIONS
Mar 21, 2025P00072$0PRICE DECREASE
Mar 20, 2025P00071$0PRODUCT ADDITIONS
Mar 17, 2025P00070$0LIFE CYCLE CHANGE
Feb 20, 2025P00069$0ADMIN CHANGE - NAC CM PV CHECKS
Feb 14, 2025P00066$0ADMIN CHANGE PRICE UPDATE IN NAC CM
Feb 14, 2025P00067$0ADMINISTRATIVE CHANGE - PRICE UPDATE
Feb 14, 2025P00068$0ADMINISTRATIVE CHANGE - PRICE UPDATE
Feb 7, 2025P00065$0PRODUCT ADDITIONS
Jan 14, 2025P00063$0ADD
Jan 10, 2025P00064$0PRODUCT DELETIONS
Dec 4, 2024P00062$02025 PUBLIC LAW
Oct 28, 2024P00060$0PERMANENT PRICE REDUCTION
Sep 3, 2024P00059$0ADDITION
Aug 28, 2024P00058$0ADD
Aug 19, 2024P00057$0LIFE CYCLE CHANGE
Jul 26, 2024P00056$0ADD
Apr 19, 2024P00055$0ADD
Mar 13, 2024P00054$0DECREASES
Mar 8, 2024P00052$0DELETIONS
Mar 8, 2024P00053$0PRODUCT DELETIONS
Mar 7, 2024P00051$0PRODUCT DELETIONS
Feb 26, 2024P00050$0LIFE CYCLE CHANGE
Feb 7, 2024P00049$0PRODUCT DELETIONS
Feb 2, 2024P00048$0SUBCONTRACTING PLAN
Jan 22, 2024P00047$0ADMIN CHANGE - 2024 PL UPDATE
Jan 11, 2024P00046$0LFIE CYCEL
Dec 12, 2023P00045$0PL 2024
Nov 22, 2023P00043$0LIFE CYCLE
Nov 22, 2023P00044$0DELETIONS
Oct 12, 2023P00042$0ADD
Sep 11, 2023P00041$0ADD
Sep 5, 2023P00040$0PPR
May 30, 2023P00039$0ADMIJN
May 22, 2023P00038$0TC CHANGE
May 1, 2023P00037$0ADMIN
Apr 19, 2023P00036$0PPR
Mar 28, 2023P00035$0ADD
Mar 22, 2023P00034$0ADDITION
Mar 20, 2023P00033$0DELETIONS
Mar 10, 2023P00032$0NDC CHANGE
Jan 17, 2023P00031$0PPR
Jan 12, 2023P00030$0SUBPLAN
Dec 15, 2022P00029$0PPR
Dec 8, 2022P00028$0PUBLIC LAW 2023
Nov 1, 2022P00027$0DECREASE
Oct 3, 2022P00026$0DELETIONS
Aug 15, 2022P00025$0DECREASES
Jul 22, 2022P00024$0ADD
Jun 6, 2022P00023$0DECREASE
May 26, 2022P00022$0DECREASES
May 6, 2022P00021$0DECREASE
Apr 29, 2022P00020$0DECREASES
Feb 4, 2022P00019$0PL CORRECTION
Jan 21, 2022P00018$0SUBPLAN
Jan 19, 2022P00017$0ADDITION
Jan 8, 2022P00016$0ADMINISTRATIVE CHANGE - PL 2022
Dec 6, 2021P00015$0LIFE CYCLE
Dec 1, 2021P00014$0PUBLIC LAW
Nov 22, 2021P00012$0TC CHANGE
Nov 22, 2021P00013$0PRICE DECREASE
Nov 18, 2021P00011$0LIFE CYCLE
Sep 7, 2021P00010$0ADMIN CHANGE
Aug 27, 2021P00009$0ADD
Aug 26, 2021P00008$0PPR
Aug 5, 2021P00007$0ADDITION
Jun 9, 2021P00006$0DECREASE
May 13, 2021P00005$0DECREASE
Apr 24, 2021P00004$0DELETION
Apr 15, 2021P00003$0ADDITION
Mar 30, 2021P00002$0PPR
Mar 1, 2021P00001$0NDC CHANGE
Feb 1, 20210$065 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.